Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

NCT ID: NCT05566431

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

428 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-22

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Narrative:

Worldwide, traumatic brain injury (TBI) is a leading cause of death and disability among children and adolescents. The Investigators aim to test whether pediatric TBI treatment guided by invasive intracranial pressure monitoring produces better patient outcomes than care guided by a protocol without invasive monitoring. Study findings will inform clinical practice in treating pediatric severe TBI globally. Focused didactic and experience-based learning opportunities will increase the research capacity of pediatric intensivists in Latin America.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Abstract:

Children who survive severe traumatic brain injury (sTBI) live with profound impairments that alter their development and future possibilities. Worldwide, TBI is the leading cause of death and disability for children/ adolescents with the US annual incidence 6 times greater than MS, HIV/AIDS, spinal cord injury, and breast cancer combined.

Our primary focus for scientific investigation is to conduct a high quality randomized controlled trial addressing a critical TBI management question: Does using a protocol with information from intracranial pressure (ICP) monitoring to direct treatment of children with sTBI improve outcomes vs an aggressive management protocol based on imaging and clinical examination alone? This follows on our adult ICP study which found no outcome differences and has occasioned re-thinking of treatment guidelines for sTBI patients \>13. A separate study is essential because children are not simply small adults and some treatment approaches carry age-related additional risks. Thus, study findings will inform US and global clinical practice.

This trial will be conducted in 8 Latin American pediatric ICUs where infrastructures and practice patterns are optimal for strong internal validity and resources represent trauma care in the developing world. The successful adolescent/adult BEST TRIP trial, which collected high-quality data in similar environments (cited \> 900 times) underscores the feasibility of this approach.

Specific Aim: In a Phase III randomized superiority trial in 428 children with sTBI from 8 Latin American pediatric trauma centers, test the effect on outcomes of management of sTBI guided by a protocol using information from ICP monitors vs. management using a protocol that uses imaging and clinical exams to guide treatment.

Hypothesis #1: Children with severe TBI whose acute care treatment is managed using a protocol based on data from ICP monitoring will have significantly lower mortality and better quality of life and global outcome at 6 months post-trauma than those whose treatment is managed with a protocol based on imaging and clinical exam. The primary measure of functional recovery is the PedsQL at 6 months. A secondary measure is GOSE-Peds.

Hypothesis #2: Incorporating ICP monitoring into sTBI patient care will minimize secondary complications, decrease length of stay in ICU and decrease brain-specific treatments.

Specific Aim: The Investigators will train personnel in centers new to research how to conduct high-quality scientific studies, and will extend the training for the personnel with whom the Investigators have been working, solidifying previous capacity-building efforts, and initiating new efforts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

In a Phase III multicenter, parallel-group, randomized superiority trial in 428 children with sTBI from 7 Latin American pediatric trauma centers, the objective is to test the efficacy of the treatment protocol from the Guidelines based on ICP monitoring among children with sTBI in improving global outcome measured by Pediatric Quality of Life Inventory (PedsQL) 6 mos after injury compared to treatment based on a non-invasive imaging \& clinical examination (CREVICE) protocol specifically modified for a pediatric population.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Outcome assessors will not go into the ICU when a study participant is being treated, unmasked study staff will not inform the outcome assessor which protocol was used for a participant. and outcome assessors will remind participant's parents to refrain for telling them which treatment protocol was used for the participant.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICP monitoring based Protocol

Arm one will use a consensus-developed management protocol for paediatric severe traumatic brain injury based on recommendations from the Brain Trauma Foundation Guidelines, which uses invasive intracranial pressure monitoring

Group Type ACTIVE_COMPARATOR

ICP

Intervention Type OTHER

The intervention is a management protocol that includes ICP monitoring for children with severe traumatic brain injury

No ICP Monitoring Protocol CREVICE

Arm two will use the Consensus-Revised Imaging and Clinical Examination (CREVICE) management protocol for paediatric severe traumatic brain injury based on imaging and clinical examination in the absence of invasive intracranial pressure monitoring

Group Type ACTIVE_COMPARATOR

CREVICE

Intervention Type OTHER

The intervention is a management protocol that is based on imaging and clinical examinations without ICP monitoring for children with severe traumatic brain injury

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICP

The intervention is a management protocol that includes ICP monitoring for children with severe traumatic brain injury

Intervention Type OTHER

CREVICE

The intervention is a management protocol that is based on imaging and clinical examinations without ICP monitoring for children with severe traumatic brain injury

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intracranial-pressure-monitoring-based management protocol Imaging-and-clinical-examination-based management protocol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Provision of signed and dated informed consent form by the parent(s) or guardian(s)
2. Non-penetrating TBI
3. Admission to study hospital within 24 hours of injury
4. Total GCS score ≤ 8 on admission or within first 48 hours after injury (measured using pediatric GCS 1 for children \< 2 years old and standard GCS for older children)
5. Age 1 through 12 years
6. Able to randomize:

* Within 24 hours of injury (for patients with GCS ≤ 8 on admission) OR
* Within 24 hours of deterioration (for patients deteriorating to GCS ≤ 8 within 48 hours of injury)

Exclusion Criteria

1. Motor GCS score of 6
2. GCS of 3 with bilaterally fixed and dilated pupils
3. Injury thought to be intentionally inflicted by a family member or caregiver.
Minimum Eligible Age

1 Year

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Randall M. Chesnut

Professor, School of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Randall Chesnut, MD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Washington, Harborview Medical Center

Seattle, Washington, United States

Site Status NOT_YET_RECRUITING

Fundación Hospital de la Misericordia

Bogotá, , Colombia

Site Status RECRUITING

Hospital Fundacion Amigos de la Salud

Montería, , Colombia

Site Status RECRUITING

Hospital de Niños Benjamín Bloom

San Salvador, , El Salvador

Site Status RECRUITING

Hospital Regional de Esquintla

Escuintla, , Guatemala

Site Status RECRUITING

Hospital General San Juan de Dios

Guatemala City, , Guatemala

Site Status RECRUITING

Hospital Regional de Occidente San Juan de Dios

Quetzaltenango, , Guatemala

Site Status RECRUITING

Hospital Escuela

Tegucigalpa, , Honduras

Site Status RECRUITING

Hospital de Emergencias Pediátricas

Lima, , Peru

Site Status RECRUITING

Hospital Edgardo Rebagliati Martins

Lima, , Peru

Site Status RECRUITING

Instituto Nacional de Salud del Niño - San Borja

Lima, , Peru

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Colombia El Salvador Guatemala Honduras Peru

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Randall M Chesnut, MD

Role: CONTACT

2067449322

Kelley Chaddock, BA

Role: CONTACT

2067449322

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Juan David Roa Giraldo, MD

Role: primary

3013380506

Wenci Camilo Navarro, MD

Role: backup

3004576234

Yojana Nova, MD

Role: primary

57 3245819372

Luis J Guzman, MD

Role: primary

503 7318 4077

Melvin Moisa, MD

Role: backup

+503 7160 2879

Willy Menendez, MD

Role: primary

+502 5204 4531

Sophia Posadas, MD

Role: backup

+502 4063 0100

Maria del Carmen Castro, MD

Role: primary

+502 4255 2860

Roberto Sierra, MD

Role: backup

+502 5439 8462

Andrea Mazariegos, MD

Role: primary

502 4154 9866

Elie de Leon, MD

Role: backup

+ 502 50188332

Sandra Rodriguez, MD

Role: primary

50499983875

Sandra Flores, MD

Role: backup

50499077099

Grimaldo C Ramirez, MD

Role: primary

+51 997 294 904

Yhuri Carreazo, MD

Role: backup

+51 997252543

Manuel Munaico, MD

Role: primary

51948418590

Manuel Ortiz, MD

Role: backup

51987817613

Daniel Achante, MD

Role: primary

51961090970

Patrick Caqui, MD

Role: backup

51933160526

References

Explore related publications, articles, or registry entries linked to this study.

Chesnut R, Temkin N, Pridgeon J, Sulzbacher S, Lujan S, Videtta W, Moya-Barquin L, Chaddock K, Bonow RH, Petroni G, Guadagnoli N, Hendrickson P, Ramirez Cortez G, Carreazo NY, Vargas Aymituma A, Anchante D, Caqui P, Ramirez A, Munaico Abanto M, Ortiz Chicchon M, Cenzano Ramos J, Castro Darce MDC, Sierra Morales R, Brol Lopez P, Menendez W, Posadas Gutierrez S, Kevin V, Mazariegos A, de Leon E, Rodas Barrios RE, Rodriguez S, Flores S, Alvarado O, Guzman Flores LJ, Moisa Martinez M, Gonzalez P. Development of a Randomized Trial Comparing ICP-Monitor-Based Management of Severe Pediatric Traumatic Brain Injury to Management Based on Imaging and Clinical Examination Without ICP Monitoring-Research Algorithms. Neurosurgery. 2024 Jan 1;94(1):72-79. doi: 10.1227/neu.0000000000002760. Epub 2023 Nov 13.

Reference Type DERIVED
PMID: 37955439 (View on PubMed)

Chesnut R, Temkin N, Pridgeon J, Sulzbacher S, Lujan S, Videtta W, Moya-Barquin L, Chaddock K, Bonow R, Petroni G, Guadagnoli N, Hendrickson P, Ramirez Cortez G, Carreazo NY, Vargas Aymituma A, Anchante D, Caqui P, Ramirez A, Munaico Abanto M, Ortiz Chicchon M, Cenzano Ramos J, Mazate-Mazariegos A, Castro Darce MDC, Sierra Morales R, Brol Lopez P, Menendez W, Posadas Gutierrez S, Kevin V, Mazariegos A, de Leon E, Rodas Barrios RE, Rodriguez S, Flores S, Alvarado O, Guzman Flores LJ, Moisa Martinez M, Gonzalez P. Development of a Randomized Trial Comparing ICP-Monitor-Based Management of Severe Pediatric Traumatic Brain Injury to Management Based on Imaging and Clinical Examination Without ICP Monitoring-Study Protocol. Neurosurgery. 2024 Jan 1;94(1):65-71. doi: 10.1227/neu.0000000000002582. Epub 2023 Jul 6.

Reference Type DERIVED
PMID: 37409817 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01HD106273-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STUDY00013122

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The CDR Implementation Trial
NCT03162354 COMPLETED NA